Article
A routine blood test could help to predict a patient’s likelihood to survive an aggressive form of skin cancer, researchers say.
Defining Treatment Options for Managing Chronic Atopic Dermatitis: Part 3
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Conference Recap: 2024 Society of Dermatology Physician Associates Fall Dermatology Conference
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
New Algorithm Proposes Targeted Lipase Monitoring for Pancreatic Adverse Events In Melanoma
Heart Transplant Recipients are More Susceptible to Skin Cancer